Avascular necrosis as a part of post-COVID syndrome. Case reports
https://doi.org/10.47360/1995-4484-2022-420-426
Abstract
Coronavirus disease 2019 (COVID-19) can manifest with a wide range of extrapulmonary symptoms and have longterm consequences (so-called post-covid syndrome (PCS) or “long COVID-19”). Manifestations of PCS show a wide clinical spectrum and include cardiac, pulmonary, neurological, gastrointestinal, dermatological, mental symptoms, vascular thrombosis and avascular necrosis (AVN) of the bones.
We present our own observations of the development of bone’s AVN in 3 patients who underwent COVID-19 with bilateral lung disease, in whom after 4–6 months the first signs of AVN were noted and characterized by a progressive multifocal lesion, which was accompanied by an increase of C-reactive protein concentration.
The pathogenetic mechanisms of AVN development in the framework of PCS are discussed. The importance of conservative and surgical methods in the treatment of the disease are considered. Since the development of AVN of various localizations with a long latent period is possible after COVID-19, long-term monitoring of patients is required. Further study of the problem of PCS in general and AVN in particular is required.
About the Authors
T. V. Beketova
Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation;
V.A. Nasonova Research Institute of Rheumatology;
Moscow Polytechnic University
Russian Federation
Competing Interests:
Russian Federation
Competing Interests:
121359, Moscow, Marshala Timoshenko str., 19, building 1A;
115522, Moscow, Kashirskoye Highway, 34A;
107023, Moscow, Bolshaya Semyonovskaya str., 38
N. O. Levina
Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation
Russian Federation
Russian Federation
121359, Moscow, Marshala Timoshenko str., 19, building 1A
D. O. Ladygina
Central State Medical Academy of the Administrative Directorate of the President of the Russian Federation
Russian Federation
Russian Federation
121359, Moscow, Marshala Timoshenko str., 19, building 1A
V. V. Babak
V.A. Nasonova Research Institute of Rheumatology
Russian Federation
Russian Federation
115522, Moscow, Kashirskoye Highway, 34A
M. F. Beketova
Lomonosov Moscow State University
Russian Federation
Russian Federation
119991, Moscow, Leninskie Gory, 12
T. N. Krasnova
Lomonosov Moscow State University
Russian Federation
Russian Federation
119991, Moscow, Leninskie Gory, 12
References
1. Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): An integrative classification. Int J Environ Res Public Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621
2. World Health Organization. A clinical case definition of post COVID19 condition by a Delphi consensus. URL: https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_conditionClinical_case_definition-2021.1 (Accessed 6th October 2021).
3. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re’em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019
4. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: A cohort study. Lancet. 2021;397(10270):220-232. doi: 10.1016/ S0140-6736(20)32656-8
5. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2021;75(3):e13746. doi: 10.1111/ijcp.13746
6. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al.; COVID19-ALC research group. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378-383. doi: 10.1016/j.jinf.2021.01.004
7. Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. PostCOVID-19 syndrome: The persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne). 2021;8:653516. doi: 10.3389/fmed.2021.653516
8. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo P, Cuapio A, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-266574. doi: 10.21203/rs.3.rs-266574/v1
9. Beketova T, Kulikov A, Babak V, Suprun M, Beketova M. Longterm consequences of COVID-19 among patients with rheumatic diseases. Chest. 2021;160(4):A583. doi: 10.1016/j.chest.2021.07.561
10. Kaeley N, Kabi A, Pillai A, Shankar T, Ameena MSS. PostCOVID-19 Guillain – Barré syndrome: A case report with literature review. Cureus. 2022;14(1):e21246. doi: 10.7759/cureus.21246
11. Fan BE, Umapathi T, Chua K, Chia YW, Wong SW, Tan GWL, et al. Delayed catastrophic thrombotic events in young and asymptomatic post COVID-19 patients. J Thromb Thrombolysis. 2021;51(4):971-977. doi: 10.1007/s11239-020-02332-z
12. Agarwala SR, Vijayvargiya M, Pandey P. Avascular necrosis as a part of ‘long COVID-19’. BMJ Case Rep. 2021;14(7):e242101. doi: 10.1136/bcr-2021-242101
13. Bressler MY, Pathak N, Cervellione K, Bagheri F, Epstein E, Mir A, Tamez R. New onset granulomatosis with polyangiitis associated with COVID-19. Case Rep Dermatol Med. 2021;2021:8877292. doi: 10.1155/2021/8877292
14. Kawashima S, Kishimoto M, Hibino T, Lee H, Sato Y, Komagata Y, et al. MPO-ANCA-positive microscopic polyangiitis following COVID-19 infection. Intern Med. 2022;61(4):567-570. doi: 10.2169/internalmedicine.8615-21
15. Lechien JR, Hervochon R, Hans S. Post-COVID-19 Kawasakilike syndrome. Ear Nose Throat J. 2021 Mar 26:1455613211006011. doi: 10.1177/01455613211006011
16. Ficat RP. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surg Br. 1985;67(1):3-9. doi: 10.1302/0301-620X.67B1.3155745
17. Karaarslan F, Güneri FD, Kardeş S. Long COVID: Rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clin Rheumatol. 2022;41(1):289-296. doi: 10.1007/s10067-021-05942-x
18. Alkindi F, Nokhatha SA, Alseiari K, Alnaqbi KA. Reactive hip arthritis and avascular necrosis after severe COVID-19 infection: A case report and comprehensive review of literature. EMJ. 2022;7(1):48-55. doi: 10.33590/emj/21-00261
19. Li W, Huang Z, Tan B, Chen G, Li X, Xiong K, et al. General recommendation for assessment and management on the risk of glucocorticoid-induced osteonecrosis in patients with COVID-19. J Orthop Translat. 2021;31:1-9. doi: 10.1016/j.jot.2021.09.005
20. Hussein S, Suitner M, Béland-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, et al. Monitoring of osteonecrosis in systemic lupus erythematosus: A systematic review and metaanalysis. J Rheumatol. 2018;45(10):1462-1476. doi: 10.3899/jrheum.170837
21. Chan KL, Mok CC. Glucocorticoid-induced avascular bone necrosis: Diagnosis and management. Open Orthop J. 2012;6: 449-457. doi: 10.2174/1874325001206010449
22. Drescher W, Schlieper G, Floege J, Eitner F. Steroid-related osteonecrosis – an update. Nephrol Dial Transplant. 2011;26(9):2728-2731. doi: 10.1093/ndt/gfr212
23. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum. 2002;32(2):94-124.
24. Mont MA, Pivec R, Banerjee S, Issa K, Elmallah RK, Jones LC. High-dose corticosteroid use and risk of hip osteonecrosis: Metaanalysis and systematic literature review. J Arthroplasty. 2015;30(9):1506-1512.e5. doi: 10.1016/j.arth.2015.03.036
25. Gangji V, Soyfoo MS, Heuschling A, Afzali V, Moreno-Reyes R, Rasschaert J, et al. Non traumatic osteonecrosis of the femoral head is associated with low bone mass. Bone. 2018;107:88-92. doi: 10.1016/j.bone.2017.11.005
26. Inoue S, Igarashi M, Karube S, Oda H. Vitamin D3 metabolism in idiopathic osteonecrosis of femoral head. Nihon Seikeigeka Gakkai Zasshi. 1987;61(6):659-666.
27. LaVergne SM, Stromberg S, Baxter BA, Webb TL, Dutt TS, Berry K, et al. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. BMC Infect Dis. 2021;21(1):677. doi: 10.1186/s12879-021-06359-2
28. Nasonov EL, Beketova TV, Reshetnyak TM, Lila AM, Ananieva LP, Lisitsyna TA, et al. Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: At the crossroads of thromboinflammation and autoimmunity. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58 (4):353-367 (In Russ.). doi: 10.47360/1995-4484-2020-353-367
29. Lo MW, Kemper C, Woodruff TM. COVID-19: Complement, coagulation, and collateral damage. J Immunol. 2020;205(6):1488- 1495. doi: 10.4049/jimmunol.2000644
30. Jose RJ, Manuel A. COVID-19 cytokine storm: The interplay between inflammation and coagulation. Lancet Respir Med. 2020;8(6):e46-e47. doi: 10.1016/S2213-2600(20)30216-2
31. Awosanya OD, Dalloul CE, Blosser RJ, Dadwal UC, Carozza M, Boschen K, et al. Osteoclast-mediated bone loss observed in a COVID-19 mouse model. Bone. 2022;154:116227. doi: 10.1016/j.bone.2021.116227
32. Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. Neutrophil extracellular traps in COVID-19. JCI Insight. 2020;5(11):e138999. doi: 10.1172/jci.insight.138999
33. Zuo Y, Zuo M, Yalavarthi S, Gockman K, Madison JA, Shi H, et al. Neutrophil extracellular traps and thrombosis in COVID-19. medRxiv. 2020.04.30.20086736. doi: 10.1101/2020.04.30.20086736
34. Zamorano Cuervo N, Grandvaux N. ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities. Elife. 2020;9:e61390. doi: 10.7554/eLife.61390
35. D Orth SA, Vijayvargiya M. A paradigm shift in osteonecrosis treatment with bisphosphonates: A 20-year study. JB JS Open Access. 2021;6(4):e21.00042. doi: 10.2106/JBJS.OA.21.00042
36. Zhang S, Wang C, Shi L, Xue Q. Beware of steroid-induced avascular necrosis of the femoral head in the treatment of COVID-19-experience and lessons from the SARS epidemic. Drug Des Devel Ther. 2021;15:983-995. doi: 10.2147/DDDT.S298691
37. Xi H, Tao W, Jian Z, Sun X, Gong X, Huang L, et al. Levodopa attenuates cellular apoptosis in steroid-associated necrosis of the femoral head. Exp Ther Med. 2017;13(1):69-74. doi: 10.3892/etm.2016.3964
38. Agarwala S, Vijayvargiya M. Bisphosphonate combination therapy for non-femoral avascular necrosis. J Orthop Surg Res. 2019;14(1):112. doi: 10.1186/s13018-019-1152-7
39. Arai R, Takahashi D, Inoue M, Irie T, Asano T, Konno T, et al. Efficacy of teriparatide in the treatment of nontraumatic osteonecrosis of the femoral head: A retrospective comparative study with alendronate. BMC Musculoskelet Disord. 2017;18(1):24. doi: 10.1186/s12891-016-1379-y
40. Horikawa A, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y, Kodama H, et al. Treatment of spontaneous osteonecrosis of the knee by daily teriparatide: A report of 3 cases. Medicine (Baltimore). 2020;99(5):e18989. doi: 10.1097/MD.0000000000018989
41. Koren L, Ginesin E, Melamed Y, Norman D, Levin D, Peled E. Hyperbaric oxygen for stage I and II femoral head osteonecrosis. Orthopedics. 2015;38(3):e200-e205. doi: 10.3928/01477447-20150305-57
42. Xie L, Liu Y, Fan B, Xiao Y, Tian Q, Chen L, et al. Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. Respir Res. 2005;6(1):5. doi: 10.1186/1465-9921-6-5
43. Ludwig J, Lauber S, Lauber HJ, Dreisilker U, Raedel R, Hotzinger H. High-energy shock wave treatment of femoral head necrosis in adults. Clin Orthop Relat Res. 2001;(387):119-126. doi: 10.1097/00003086-200106000-00016
44. Ding S, Peng H, Fang HS, Zhou JL, Wang Z. Pulsed electromagnetic fields stimulation prevents steroid-induced osteonecrosis in rats. BMC Musculoskelet Disord. 2011;12:215. doi: 10.1186/1471-2474-12-215
45. Torgashin AN, Rodionova SS, Shumsky AA, Makarov MA, Torgashina AV, Akhtyamov IF, et al. Treatment of aseptic necrosis of the femoral head. Clinical guidelines. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2020;58(6):637-645 (In Russ.). doi: 10.47360/1995-4484-2020-637-645
46. Sodhi N, Acuna A, Etcheson J, Mohamed N, Davila I, Ehiorobo JO, et al. Management of osteonecrosis of the femoral head. Bone Joint J. 2020;102-B(7_Supply_B):122-128. doi: 10.1302/0301-620X.102B7.BJJ-2019-1611.R1
Review
For citations:
Beketova T.V., Levina N.O., Ladygina D.O., Babak V.V., Beketova M.F., Krasnova T.N. Avascular necrosis as a part of post-COVID syndrome. Case reports. Rheumatology Science and Practice. 2022;60(4):420-426. (In Russ.) https://doi.org/10.47360/1995-4484-2022-420-426
Views:
1048
Email this article 